U.S. Federal Reserve confirms July 27 meeting on Basel III endgame capital proposals for banks
By Steve Gelsi
Basel III endgame proposal goes to full vote by the Federal Reserve Board as regulators look to strengthen the financial system
The Federal Reserve Board has scheduled a July 27 open meeting to air proposed rules to implement the Basel III endgame agreement for large banks, as well as capital surcharges for the largest and most complex banks.
The move by the Fed late Monday comes after reports last week of the gathering by Federal banking regulators to bring the country's rules in line with the international Basel III accords put into place in the wake of the Global Financial Crisis of 2008.
The version may include rule changes around residential mortgage capital requirements for larger banks that may go beyond measures already in place in other countries, as reported by Bloomberg.
TD Cowen analyst Jaret Seiberg said it's expected that the Fed will require capital proposals averaging 200 basis points, or 2%, for banks, although it will vary depending on the bank.
Other forecasted changes by the Fed include how regional banks handle unrealized gains and losses on their available-for-sale (AVS) securities.
The Fed's Basel III endgame proposal will include AFS capital treatment for all banks with at least $100 billion of assets, Seiberg said.
The meeting comes after Michael S. Barr, vice chair for supervision at the U.S. Federal Reserve, said on July 10 he's leading a multiyear effort to increase capital requirements for banks in the wake of three bank failures earlier this year.
Bank industry proponents have said that many such changes are not necessary and that they will raise the cost of borrowing for consumers and business owners.
Still to come on the regulatory front, the Federal Reserve is also working on changes to its annual stress test, which is expected in the coming weeks, Seiberg said.
Also read:Fed's Michael Barr proposes new capital requirements for banks with $100 billion or more in assets
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-21-23 0800ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
What’s Happening In the Markets This Week
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
After Earnings, Is Lyft Stock a Buy, a Sell, or Fairly Valued?
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing